According to ARS Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$0.57. In 2022 the company made an earnings per share (EPS) of -$0.87 a decrease over its 2021 EPS that were of -$0.22.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$0.57 | -34.46% |
2022 | -$0.87 | 303% |
2021 | -$0.22 | 1800.68% |
2020 | -$0.01136 |